Related Experiment Video
Updated: May 21, 2026

Immunohistochemical Staining of B7-H1 (PD-L1) on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
The expression, function, and clinical relevance of B7 family members in cancer
Barbara Seliger1, Dagmar Quandt
1Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Magdeburger Strasse 2, Halle (Saale), Germany. barbara.seliger@uk-halle.de
Abstract:
The modulation and suppression of anti-tumor immune responses is a characteristic feature of tumor cells to escape immune surveillance. Members of the B7 family are involved in this process, since the level of activation of the anti-tumor immune response depends on the balance between co-stimulatory and co-inhibitory signals. Some molecules are often overexpressed in tumors, which has been associated with the pathogenesis and progression of malignancies as well as their immunological and non-immunological functions. The B7 homologs play a key role in the maintenance of self-tolerance and the regulation of both innate and adaptive immunity in tumor-bearing hosts. Furthermore, the blockade of negative signals mediated by the interaction of co-inhibitory ligands and counter-receptors of the B7 family is currently being studied as a potential immunotherapeutic strategy for the treatment of cancer in humans.
Insights
Tumor cells suppress immune responses using B7 family molecules to evade detection. Blocking these inhibitory signals offers a promising cancer immunotherapy strategy.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Tumor cells evade immune surveillance by modulating anti-tumor immune responses.
- The B7 family of molecules plays a critical role in regulating immune responses through co-stimulatory and co-inhibitory signals.
- Overexpression of certain B7 family members in tumors is linked to cancer progression and immune evasion.
Purpose of the Study:
- To investigate the role of B7 family molecules in tumor immune evasion.
- To explore the potential of targeting B7 family interactions for cancer immunotherapy.
Main Methods:
- Analysis of B7 family molecule expression in tumor cells.
- Studies on the balance of co-stimulatory and co-inhibitory signals in the tumor microenvironment.
- Evaluation of strategies to block inhibitory B7-mediated signals.
Main Results:
- B7 family molecules are key regulators of immune cell activation and tolerance in cancer.
- Dysregulation of B7 family interactions contributes to tumor immune suppression.
- Blocking co-inhibitory B7 signals shows potential for enhancing anti-tumor immunity.
Conclusions:
- Targeting B7 family interactions represents a viable immunotherapeutic approach for cancer treatment.
- Understanding the B7 network is crucial for developing effective cancer immunotherapies.
- Modulating immune checkpoints via B7 blockade can overcome tumor-induced immune suppression.
Related Concept Videos
Mitogens and the Cell Cycle
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
